USP18 and acute promyelocytic leukemia: Besides our report, USP18 has been reported to directly maintain oncogene stability such as the chimeric, dominant-negative-acting transcription factor promyelocytic leukemia gene (PML)/RARa during acute promyelocytic leukemia development[34].